Furthermore, the Gleason grading system is an important prognostic factor not only for localized PCa but also for metastatic PCa treated with second-generation androgen receptor axis-targeted agents, the most current agents of this era [8]. The gene discussed is AR; the disease is posterior cortical atrophy.